Cellphone-based microscope leads to possible strategy for treating river blindness

November 9, 2017, National Institutes of Health

River blindness, or onchocerciasis, is a disease caused by a parasitic worm found primarily in Africa. The worm (Onchocerca volvulus) is transmitted to humans as immature larvae through bites of infected black flies. Symptoms of infection include intense itching and skin nodules. Left untreated, infections in the eye can cause vision impairment that leads to blindness. Mass distribution of ivermectin is currently used to treat onchocerciasis. However, this treatment can be fatal when a person has high blood levels of another filarial worm, Loa loa.

In a paper published in the New England Journal of Medicine, scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and other organizations describe how a cell phone-based videomicroscope can provide fast and effective testing for L. loa parasites in the , allowing these individuals to be protected from the adverse effects of .

In the new study, 16,259 volunteers in 92 villages in Cameroon where both L. loa and O. volvulus are commonly found provided finger-prick blood samples. These samples were then tested for L. loa using the LoaScope, a small microscope that incorporates a cell phone. Developed by a team led by researchers from NIAID and the University of California, Berkeley, the LoaScope returns test results in less than three minutes. Volunteers who were not infected or who had low-level L. loa infections were given standard ivermectin treatment and observed closely for six days afterwards. Volunteers with high numbers of L. loa parasites in their blood did not receive ivermectin.

Using this strategy, 15,522 study volunteers were successfully treated with ivermectin without serious complications. Nearly 1,000 participants experienced mild following ivermectin treatment. According to the study authors, the LoaScope could be a valuable approach in the fight against by effectively targeting populations for ivermectin treatment, and protecting dually-infected patients from complications of inadvertent ivermectin administration.

Explore further: Decades-long quest to beat river blindness edges towards vaccine

More information: Joseph Kamgno et al. A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa–Endemic Areas, New England Journal of Medicine (2017). DOI: 10.1056/NEJMoa1705026

Related Stories

Decades-long quest to beat river blindness edges towards vaccine

January 11, 2016
The world's first vaccine for a disease that causes misery for millions in Africa could be tested within five years.

For rosacea, ivermectin offers lasting improvement in HRQoL

April 14, 2016
(HealthDay)—For patients with rosacea, ivermectin treatment is associated with long-term improvement in health-related quality of life (HRQoL), according to a study published online April 8 in the British Journal of Dermatology.

Recommended for you

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

Flu shot only 36 percent effective, making bad year worse (Update)

February 15, 2018
The flu vaccine is doing a poor job protecting older Americans and others against the bug that's causing most illnesses.

IFN-mediated immunity to influenza A virus infection influenced by RIPK3 protein

February 15, 2018
Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37 children have died in the United States ...

A new class of drug to treat herpes simplex virus-1 infection

February 14, 2018
For patients with the herpes simplex-1 virus (HSV-1), there are just a handful of drugs available to treat the painful condition that can affect the eyes, mouth and genitals.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.